TransCode Therapeutics Inc (RNAZ)
1.16
+0.35
(+42.38%)
USD |
NASDAQ |
May 07, 16:00
1.12
-0.04
(-3.45%)
After-Hours: 04:51
TransCode Therapeutics Total Liabilities (Quarterly): 3.529M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.529M |
| September 30, 2023 | 5.788M |
| June 30, 2023 | 3.789M |
| March 31, 2023 | 5.827M |
| December 31, 2022 | 4.347M |
| September 30, 2022 | 3.771M |
| June 30, 2022 | 1.727M |
| Date | Value |
|---|---|
| March 31, 2022 | 1.849M |
| December 31, 2021 | 2.534M |
| September 30, 2021 | 2.205M |
| June 30, 2021 | 6.558M |
| March 31, 2021 | 8.884M |
| December 31, 2020 | 4.464M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.727M
Minimum
Jun 2022
8.884M
Maximum
Mar 2021
4.252M
Average
3.789M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Citius Pharmaceuticals Inc | 12.07M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.170M |
| Shareholders Equity (Quarterly) | 1.641M |